MYGN

Myriad Genetics, Inc. News Headlines

$39.7
*  
0.30
 negative 
0.76%
Get MYGN Alerts
*Delayed - data as of Apr. 23, 2014 15:38 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Meridian Bioscience Inc. (VIVO) Ex-Dividend Date Scheduled for May 01, 2013
4/30/2013 9:00:04 AM - NASDAQ.com News

Myriad Genetics: Growth Stock, Hot Sector, Solid Industry
4/22/2013 4:55:00 AM - Seeking Alpha

Myriad Downgraded to Neutral - Analyst Blog
4/18/2013 3:10:46 PM - Zacks.com

Tuesday Options Brief: UNH, MYGN & OMPI
4/2/2013 12:50:00 PM - Seeking Alpha

Myriad's New Alliance for HRD Test - Analyst Blog
3/28/2013 2:27:42 PM - Zacks.com

Myriad Retained at Outperform - Analyst Blog
3/8/2013 10:50:01 AM - Zacks.com

Positive Data on Myriad's Prolaris - Analyst Blog
3/6/2013 3:55:01 PM - Zacks.com

Still Neutral on Edwards - Analyst Blog
3/5/2013 6:20:01 PM - Zacks.com

Merge Extends Hyland Partnership - Analyst Blog
3/5/2013 3:40:01 PM - Zacks.com

Reimbursement Update for Myriad - Analyst Blog
3/4/2013 3:40:01 PM - Zacks.com

Collaborative Research for Cepheid - Analyst Blog
2/21/2013 3:20:01 PM - Zacks.com

Qiagen in Collaboration with Lilly - Analyst Blog
2/15/2013 3:20:01 PM - Zacks.com

Myriad Tops Estimates; Tweaks View - Analyst Blog
2/8/2013 3:30:01 PM - Zacks.com

Myriad Genetics, Inc. Enters Oversold Territory - Tale of the Tape
2/8/2013 11:48:01 AM - Zacks.com

Impressive 4Q for Qiagen - Analyst Blog
1/30/2013 9:50:01 AM - Zacks.com

Qiagen Seeks FDA Approval - Analyst Blog
1/18/2013 6:00:01 PM - Zacks.com

Qiagen Beats 2012 Placement Target - Analyst Blog
1/15/2013 9:50:01 AM - Zacks.com

Intuitive Surgical: A Strong Buy - Analyst Blog
1/2/2013 12:30:01 PM - Zacks.com

Myriad Alleviates to Outperform - Analyst Blog
12/21/2012 5:10:01 PM - Zacks.com

Aggressive Growth: Myriad Genetics
12/19/2012 10:32:00 AM - Seeking Alpha

Myriad Genetics - Aggressive Growth
12/19/2012 1:00:01 AM - Zacks.com

Genomic Presents Oncotype Results - Analyst Blog
12/13/2012 11:50:01 AM - Zacks.com

Can Amgen Unlock DeCODE's Value?
12/10/2012 12:44:00 PM - Seeking Alpha

Meridian Bioscience Inc. (VIVO) Ex-Dividend Date Scheduled for December 12, 2012
12/10/2012 10:00:04 AM - NASDAQ.com News

Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics
11/30/2012 9:02:00 AM - Seeking Alpha